Jules C. Beal

Dr. Jules C. Beal serves as Assistant Professor of Clinical Pediatrics at Weill Cornell Medicine and attending pediatric neurologist at NewYork-Presbyterian Queens, specializing in complex pediatric neurological disorders with emphasis on epilepsy management and neurocutaneous syndromes.

His educational credentials include:

• M.D. from Mount Sinai School of Medicine (2007)
• B.S. from Villanova University (2003)

Research focuses on epilepsy (particularly childhood seizures and epileptic encephalopathies), neurocutaneous disorders (neurofibromatosis, tuberous sclerosis), and migraine pathophysiology. He directs specialty clinics for neurocutaneous and neurogenetic conditions, investigating neurologic manifestations of complex systemic diseases through both clinical practice and translational research.

Analysis of his 15 most recent publications (2011-2025) reveals dominant themes in pediatric epilepsy treatment optimization, including cannabidiol trials, surgical candidate identification, and EEG-based diagnostic innovation. His work increasingly integrates genomic medicine (NYCKidSeq project) while maintaining strong emphasis on quality improvement in acute seizure management and neurodiagnostics.

Major recognitions include:

• New York SuperDoctors (2019)
• International League Against Epilepsy Leadership Program Awardee (2017)
• Al Spiro Resident Teaching Award (2019)
• Isabelle Rapin Scholarly Activity Award (2012)

As an educator, Dr. Beal regularly lectures at American Epilepsy Society and International League Against Epilepsy conferences. His grant-funded work includes protocol-driven status epilepticus management, folic acid supplementation initiatives for women with epilepsy, and implementation of continuous EEG monitoring systems. He directs hospital-based quality improvement projects addressing critical gaps in pediatric neurocritical care.

He maintains active leadership in specialty clinics for neurocutaneous disorders and neurogenetic conditions at NewYork-Presbyterian Queens, developing multidisciplinary care pathways for children with tuberous sclerosis, Sturge-Weber syndrome, and related complex neurogenetic syndromes.